Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/25/18
End: 10/05/18
Due: 10/05/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Vedolizumab Induction May Prevent Celiac Enteritis | NCT02929316 | AGA Clinical Research Associates, LLC | user2@example.com | None | 2018-06-25 | 2018-10-05 | 2019-10-05 | - | - | 2025-07-14 |